Learn About Alkaptonuria

What is the definition of Alkaptonuria?

Alkaptonuria is an inherited condition that causes urine to turn black when exposed to air. Ochronosis, a buildup of dark pigment in connective tissues such as cartilage and skin, is also characteristic of the disorder. This blue-black pigmentation usually appears after age 30. People with alkaptonuria typically develop arthritis, particularly in the spine and large joints, beginning in early adulthood. Other features of this condition can include heart problems, kidney stones, and prostate stones.

Save information for later
Sign Up
What are the causes of Alkaptonuria?

Mutations in the HGD gene cause alkaptonuria. The HGD gene provides instructions for making an enzyme called homogentisate oxidase. This enzyme helps break down the amino acids phenylalanine and tyrosine, which are important building blocks of proteins. Mutations in the HGD gene impair the enzyme's role in this process. As a result, a substance called homogentisic acid, which is produced as phenylalanine and tyrosine are broken down, accumulates in the body. Excess homogentisic acid and related compounds are deposited in connective tissues, which causes cartilage and skin to darken. Over time, a buildup of this substance in the joints leads to arthritis. Homogentisic acid is also excreted in urine, making the urine turn dark when exposed to air.

How prevalent is Alkaptonuria?

This condition is rare, affecting 1 in 250,000 to 1 million people worldwide. Alkaptonuria is more common in certain areas of Slovakia (where it has an incidence of about 1 in 19,000 people) and in the Dominican Republic.

Is Alkaptonuria an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Alkaptonuria Local Doctors?
Elite
Highly rated in
9
conditions

University Of Liverpool

Liverpool, ENG, GB 

Lakshminarayan Ranganath is in Liverpool, United Kingdom. Ranganath is rated as an Elite expert by MediFind in the treatment of Alkaptonuria. They are also highly rated in 9 other conditions, according to our data. Their top areas of expertise are Ochronosis, Alkaptonuria, Tyrosinemia Type 1, and Tyrosinemia Type 3.

Elite
Highly rated in
3
conditions

Università Degli Studi Di Siena

Siena, IT 53100

Daniela Braconi is in Siena, Italy. Braconi is rated as an Elite expert by MediFind in the treatment of Alkaptonuria. She is also highly rated in 3 other conditions, according to our data. Her top areas of expertise are Ochronosis, Alkaptonuria, Inborn Amino Acid Metabolism Disorder, and Primary Amyloidosis.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
7
conditions

University Of Liverpool

Liverpool, ENG, GB 

James Gallagher is in Liverpool, United Kingdom. Gallagher is rated as an Elite expert by MediFind in the treatment of Alkaptonuria. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are Ochronosis, Alkaptonuria, Tyrosinemia Type 1, and Monoamine Oxidase A Deficiency.

What are the latest Alkaptonuria Clinical Trials?
Determining Individualised Gait Modification Strategies to Reduce Knee Joint Moments in Alkaptonuria Patients Using Real-time Feedback
Match to trials
Find the right clinical trials for you in under a minute
Get started
Clinical, Biochemical, and Molecular Investigations Into Alkaptonuria
Who are the sources who wrote this article ?

Published Date:updated Last, November

Published By: National Institutes of Health

What are the Latest Advances for Alkaptonuria?
Alkaptonuria with rapidly destructive arthropathy of the hip: A case report and literature review.
Variant Analysis of Alkaptonuria Families with Significant Founder Effect in Jordan.
Tired of the same old research?
Check Latest Advances
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.